Image

Prolonged Hospital Stay After Thoracoscopic Anatomical Lung Resections

Prolonged Hospital Stay After Thoracoscopic Anatomical Lung Resections

Recruiting
18 years and older
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

In this study, the reasons for prolonged hospital stay after thoracoscopic (video- or robot-assisted) anatomical lung resections are investigated. Currently, whenever possible, these anatomical lung resections are performed thoracoscopically, as they offer significant improvements in terms of postoperative pain, number of postoperative complications, rehabilitation, tolerance for adjuvant chemotherapy, and length of hospital stay. The development of an 'Enhanced Recovery After Surgery' (ERAS) protocol for lung surgery has further reduced hospital stay and the need for opioids for analgesia. Despite the optimal implementation of the ERAS protocol, there are still patients who need to stay in the hospital longer than the median. The aim of this research is to investigate the reasons for this.

Eligibility

Inclusion Criteria:

  • Patients referred for elective minimally invasive (uniportal or multiportal videoor robot-assisted) anatomical lung resection (lobectomy or segmentectomy)
  • Informed consent obtained pre-operatively
  • Age 18 years or older

Exclusion Criteria:

  • Patients younger than 18 years old
  • Traumatic event as indication for lung resection
  • Non-anatomical lung resections
  • Thoracotomy
  • Patients already hospitalized for other pathologies, pre-existent and not related to the lung surgery
  • Urgent/emergency procedures

Study details
    Minimally Invasive Surgical Procedures
    VATS
    RATS Surgery
    Pulmonary Lobectomy
    Pulmonary Segmentectomy
    Air Leakage
    Postoperative Complication
    Pain Postoperative

NCT06638645

University Hospital, Ghent

15 October 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.